Detalhe da pesquisa
1.
An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
J Biol Chem
; 288(27): 19593-603, 2013 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23696648